Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy.

J Contemp Brachytherapy · 2018 · PMC6142650 · PMID 30237816

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

A strong trend towards improved 5-year survival is also noted if intracavitary insertion is ideal (60% vs. 40%) in patients with locally advanced cervical cancer [ 8 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.